European surveillance study on the antibiotic susceptibility of Propionibacterium acnes

C Oprica1, C E Nord,

  • 1Department of Laboratory Medicine, Division of Clinical Bacteriology, Karolinska Institute, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.

Insights

Antimicrobial resistance has emerged in Propionibacterium acnes (P. acnes) systemic infections across Europe. Resistance to clindamycin and erythromycin was observed, with significant country-to-country variations in P. acnes antibiotic susceptibility patterns.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Propionibacterium acnes (P. acnes) is implicated in various infections, including those associated with surgical procedures and foreign bodies.
  • Understanding the antibiotic susceptibility of P. acnes is crucial for effective treatment of systemic infections.

Purpose of the Study:

  • To investigate antibiotic susceptibility patterns of P. acnes isolates from diverse systemic infections across Europe.
  • To determine the genomic diversity among resistant P. acnes isolates using pulsed-field gel electrophoresis (PFGE).

Main Methods:

  • A total of 304 P. acnes isolates from 13 European countries were tested against six antimicrobial agents.
  • Antibiotic susceptibility testing was performed using the NCCLS reference agar dilution method.
  • Genomic diversity was assessed via low-frequency restriction analysis of chromosomal DNA by PFGE.

Main Results:

  • Prevalence of resistance: 2.6% to tetracycline, 15.1% to clindamycin, and 17.1% to erythromycin. No resistance to linezolid, benzylpenicillin, or vancomycin.
  • Blood isolates were most frequent among resistant strains.
  • Significant inter-country variation in resistance proportions was noted, with high rates in Croatia (83%) and Italy (60%).

Conclusions:

  • Antimicrobial resistance has emerged in P. acnes isolates causing systemic infections.
  • The findings highlight the need for ongoing surveillance of P. acnes antibiotic susceptibility.
  • Genomic analysis revealed considerable diversity among resistant P. acnes strains.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...